EDGAR Filing Documents for 0001179110-18-001882

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001179110-18-001882

Filing Date

2018-02-09

Accepted

2018-02-09 16:02:13

Documents

Period of Report

2018-02-08

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4 -	edgar.html	4
1	FORM 4 -	edgar.xml	4	4024
	Complete submission text file	0001179110-18-001882.txt		5473

Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139

Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971

CATABASIS PHARMACEUTICALS INC (Issuer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CATABASIS PHARMACEUTICALS, INC. ONE KENDALL SQ. BLDG. 1400E SUITE B14202 CAMBRIDGE MA 02139

Business Address

Type: 4 | Act: 34 | File No.: 001-37467 | Film No.: 18591637